# Hypertension-diabetes comorbidity in tropical Chinese adults

**Authors:** Jinting Zou, Junliang Tao, Juan Jiang, Changfu Xiong, Bin He, Dingwei Sun, Ying Liu, Dongxian Zhang

PMC · DOI: 10.7189/jogh.16.04091 · Journal of Global Health · 2026-03-06

## TL;DR

This study finds that hypertension and diabetes together are common in tropical Chinese adults, especially older men, and highlights the need for better disease management.

## Contribution

The study provides population-based evidence on hypertension-diabetes comorbidity in tropical China, identifying key risk factors and gaps in disease management.

## Key findings

- The weighted prevalence of hypertension-diabetes comorbidity was 7.0% in Hainan Province, increasing sharply with age.
- Overweight, obesity, and dyslipidaemia were independently associated with higher odds of comorbidity.
- Only 36.9% of diagnosed individuals reported taking blood glucose control measures, indicating poor management of diabetes.

## Abstract

Hypertension-diabetes comorbidity (HDC) substantially increases the risk of cardiovascular and microvascular complications, yet population-based evidence from tropical island settings in China remains limited. This study estimated the prevalence of HDC among adults in Hainan Province and examined associated factors across sociodemographic, metabolic, and lifestyle domains.

We analysed data from the Hainan Province ‘2 + 3’ health service package epidemiological survey, a population-based cross-sectional study conducted across all 24 administrative divisions from 3 November to 31 December 2022 using a two-stage disproportionate cluster sampling design. After prespecified data quality control and cleaning, 32 857 adults were included. Survey weights were applied to produce population-representative estimates, and survey-weighted multivariable logistic regression was used to identify factors associated with HDC.

The weighted prevalence of HDC was 7.0%, higher in men (8.0%) than women (6.0%), and increased sharply with age (1.6% in 18–39 years, 7.7% in 40–59 years, and 18.5% in ≥ 60 years). In the fully adjusted model, female sex was inversely associated with HDC (adjusted odds ratio (aOR) = 0.64; 95% confidence interval (CI) = 0.55–0.74), while older age (40–59 years: aOR = 5.42; 95% CI = 4.29–6.85), (≥ 60 years: aOR = 16.37; 95% CI = 13.38–20.04) and Li ethnicity (aOR = 1.60; 95% CI = 1.20–2.14) were associated with higher odds. Overweight (aOR = 1.83; 95% CI = 1.63–2.06), obesity (aOR = 2.68; 95% CI = 2.28–3.15), and dyslipidaemia (aOR = 1.74; 95% CI = 1.58–1.92) were independently associated with HDC, whereas underweight showed an inverse association (aOR = 0.67; 95% CI = 0.52–0.86). Among participants with self-reported diagnosed hypertension and diabetes, 66.8% reported taking any blood pressure control measure and 36.9% reported taking any blood glucose control measure, respectively.

In tropical China, HDC affects a substantial proportion of adults and is strongly associated with male sex, older age, excess adiposity, and dyslipidaemia. The low uptake of diabetes control measures among diagnosed individuals highlights the need to strengthen integrated screening, follow-up, and chronic disease management in this setting.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** hepatitis (MESH:D056486), tuberculosis (MESH:D014376), underweight (MESH:D013851), Type 2 Diabetes (MESH:D003924), nephropathy (MESH:D007674), adiposity (MESH:D018205), hypercholesterolemia (MESH:D006937), chronic disease (MESH:D002908), hypertriglyceridemia (MESH:D015228), deaths (MESH:D003643), HDC (MESH:D006973), viral hepatitis (MESH:D014777), hyperbetalipoproteinemia (MESH:D006938), insulin resistance (MESH:D007333), cardiovascular and microvascular complications (MESH:D002318), pulmonary tuberculosis (MESH:D014397), ischemic heart disease (MESH:D017202), NCDs (MESH:D000073296), retinopathy (MESH:D058437), stroke (MESH:D020521), Overweight (MESH:D050177), hypoalphalipoproteinemia (MESH:D052456), obese (MESH:D009765), metabolic disorders (MESH:D008659), complications (MESH:D008107), hepatitis B (MESH:D006509), mental disorders (MESH:D001523), impaired (MESH:D060825), Diabetes (MESH:D003920)
- **Chemicals:** Lipid (MESH:D008055), glucose (MESH:D005947), alcohol (MESH:D000438), TC (-), potassium oxalate (MESH:D019815), sodium fluoride (MESH:D012969), cholesterol (MESH:D002784), blood glucose (MESH:D001786), salt (MESH:D012492), sugar (MESH:D000073893), TG (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12964091/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964091/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12964091/full.md

---
Source: https://tomesphere.com/paper/PMC12964091